Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) just unveiled an update.
Jiangsu Recbio Technology Co., Ltd. has completed the payment and capital verification for its issuance of 143,112,702 domestic shares, priced at RMB5.59 each, resulting in net proceeds of RMB789,985,366.85. This successful issuance marks a significant step in the company’s financial operations, potentially enhancing its market positioning and providing additional resources for future growth initiatives.
The most recent analyst rating on (HK:2179) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Jiangsu Recbio Technology Co., Ltd. Class H stock, see the HK:2179 Stock Forecast page.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology industry. The company is focused on the development and issuance of domestic shares, aiming to strengthen its market position and financial standing.
Average Trading Volume: 49,870
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.21B
Learn more about 2179 stock on TipRanks’ Stock Analysis page.